INTRODUCTION
The human gastrointestinal tract is colonized by a complex community of micro-organisms that plays a key protective role during enteric infections (Stecher & Hardt, 2008) . Infectious gastroenteritis caused by non-typhoidal strains of Salmonella enterica subsp. enterica is an important cause of morbidity and mortality worldwide, especially in young children (Crum-Cianflone, 2008; Viswanathan et al., 2009 ). Due to an increasing incidence of antibiotic-resistant and more infective serovars (Kingsley et al., 2009) , the use of probiotics with specific anti-Salmonella activities is of current interest. Mechanisms by which probiotics inhibit pathogens include competition for nutritional substrates and adhesion sites on intestinal epithelial cells, toxin inactivation, as well as the secretion of antimicrobial substances (Collado et al., 2009) .
Bacteriocins are promising candidates as mediators of antipathogenic probiotic effects, and their ability to inhibit pathogens in vitro is well documented (Corr et al., 2009) . Corr et al. (2007) , for example, showed that Lactobacillus salivarius UCC118 is able to produce the bacteriocin Abp118 in vivo, resulting in the protection of mice against Listeria monocytogenes infection. Using an ICR mouse model infected with Listeria, Dabour et al. (2009) recently showed that intragastric administration of repeated doses of pediocin PA-1 reduces Listeria counts and pathogen translocation into the liver and spleen compared with the infected control group, leading to the disappearance of L. monocytogenes in these two organs within 6 days. However, enteric protection related to in situ bacteriocin production in human gut environments has been little studied.
Using simple in vitro activity tests, we recently showed that Escherichia coli L1000 producing microcin B17 is active against a broad panel of antibiotic-resistant and -sensitive Salmonella strains isolated in Switzerland from patients suffering from salmonellosis . Furthermore, thermophilicin B67, a bacteriocin-like inhibitory substance produced by the Gram-positive bacterium Bifidobacterium thermophilum RBL67 (von Ah, 2006; von Ah et al., 2007) , exerts strong inhibitory activity against 10 strains of the same panel belonging to six different serovars (our unpublished data). Although simple in vitro antagonist tests are useful for screening new probiotic bacteria with specific antimicrobial activity, gut environments are much more complex. Dynamic interactions between microorganisms are responsible for colonization and competition, and in maintaining a healthy balance and the barrier effect of the gut microbiota in vivo. More elaborate models involving a complex gut microbiota providing conditions closer to those found in gastrointestinal environments are therefore required for activity and mechanistic studies of potential probiotics before considering more complex and expensive in vivo testing.
A single-stage continuous fermentation model for Salmonella colonization in the proximal colon that mimics long-term shedding in children was recently developed and used to compare the effects of antibiotic therapy and B. thermophilum RBL67 on salmonellosis in child gut environments A. Zihler and others, unpublished results) . B. thermophilum RBL67 grows in the intestinal environment and exhibits a strong inhibition of Salmonella when added before (preventive) or after (curative) Salmonella, and is able to rebalance the metabolic activity of gut microbiota after antibiotic treatments. These experiments were performed with S. enterica subsp. enterica serovar Typhimurium (S. Typhimurium) M557, a strain lacking Salmonella pathogenicity island (SPI)-1 effector proteins, and deficient in SPI-1-and SPI-2-dependent type III protein secretion systems that are known to be important host-microbe virulence factors of Salmonella (Hapfelmeier et al., 2004; Ohl & Miller, 2001 ).
In the present study, we tested the effects of a combined treatment with E. coli L1000 followed by B. thermophilum RBL67 on Salmonella growth, as well as gut microbiota composition and metabolic activity, using three-stage in vitro continuous gut fermentation models (Cinquin et al., 2006 ) that mimic the infected child colon, employing S. Typhimurium N-15, a highly invasive strain that was isolated from a clinical case ). E. coli L1000 was first tested by inoculating E. coli L1000 beads into the first reactor to model a colonizing E. coli strain, while the colonization and protective effect of E. coli L1000 was assumed to occur preferentially in the distal colon reactor, close to neutral pH. B. thermophilum RBL67 was inoculated in a second step to preferentially induce a protective effect in the proximal colon reactor at the lower pH of 5.7. Two three-stage models were operated in parallel to test comparatively the effects of E. coli L1000 wild-type (wt) producing microcin B17 and the bacteriocin-negative mutant E. coli L1000 MccB172. Finally, a prebiotic treatment with inulin was tested to stimulate B. thermophilum RBL67 growth.
METHODS
Bacterial strains. S. Typhimurium N-15 was isolated in 2007 from an infected person in Switzerland and obtained from the National Center for Enteropathogenic Bacteria (NENT; Luzern, Switzerland). This strain was selected for its high invasion rate into mucus-secreting intestinal HT29-MTX cells compared with other Salmonella strains obtained from clinical cases, accompanied by a high disruption of epithelial integrity as revealed by transepithelial electrical resistance (TER) measurements (our unpublished data). It was routinely cultivated in tryptic soy broth (TSB; Difco) at 37 uC for 18 h.
E. coli L1000 wt was provided by Laves-Arzneimittel. E. coli L1000 MccB172, lacking the microcin B17 phenotype, was constructed as described below. E. coli NCTC 50154, obtained from the UK National Collection of Type Cultures, was used as a microcin B17-sensitive indicator organism. E. coli strains were routinely grown on LuriaBertani agar (LB; Becton Dickinson) for 18 h at 37 uC.
B. thermophilum RBL67 (our culture collection) was routinely grown at 37 uC for 18 h anaerobically in de Man Rogosa Sharpe broth supplemented with 0.05 % (w/v) L-cysteine HCl (MRSC; SigmaAldrich) in anaerobic jars with the AnaeroGen atmosphere generation system (Oxoid).
Mutant construction. The operon mcbABCDEFG, encoding microcin B17 production and immunity, was chosen as a target for gene deletion using the Quick & Easy E. coli Gene Deletion kit from Gene Bridges (BioCat) according to the manufacturer's protocol. First, a PCR product of the FRT-PGK-gb2-neo-FRT cassette containing the flanking regions of mcbABCDEFG was amplified using the primers mcbA upper and mcbG lower (Table 1) . The resulting 1737 bp product contained the FRT-PGK-gb2-neo-FRT cassette flanked by 50 bp up-and downstream regions of mcbABCDEFG introduced in the primers. The strain E. coli L1000 wt was transformed by electroporation with plasmid pRedET carrying the genes for recombination, resulting in strain E. coli L1000-pRedET. The linear FRT-PGK-gb2-neo-FRT-mcbABCDEFG fragment was transformed by electroporation into E. coli L1000-pRedET and after induction of recombination, primary integrants were selected on LB agar containing 15 mg kanamycin ml 21 . Integrants were checked for site-specific integration by PCR using the primer pairs mcbA upper-control/ Primer 2 (Table 1) , annealing in the upstream and cassette promoter regions, and primer set Primer 3/mcbG lower-control, annealing in the downstream region and the kanamycin-resistance gene. The strain L1001, displaying the correct PCR profile, was cured according to the manufacturer's protocol, resulting in the mcbABCDEFG-deletion strain E. coli L1000 MccB172. The mutant was checked for a microcin B17-negative phenotype using a modified protocol of the double-agar layer assay described by Kheadr et al. (2010) . Briefly, 2 ml of overnight cultures of E. coli L1000 wt and E. coli L1000 MccB172 were spotted onto the surface of LB agar (1.5 %, w/v) and plates were left to dry aseptically for 30 min. After incubation at 37 uC for 18 h, colonies were treated with 10 ml chloroform (Sigma-Aldrich) for 1 min in closed Petri dishes and subsequently dried in opened dishes. A second layer of 15 ml LB agar (0.8 %, w/v) seeded with 1 % (v/v) of an 
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Microbiology 156 overnight culture of the indicator strain E. coli NCTC 50154 or S. Typhimurium N-15 was poured on the plates. After agar solidification, plates were incubated at 37 uC for 18 h and checked for the absence of inhibition zones.
Bacterial immobilization. A faecal sample (~5 g) from a healthy 2-year-old child (male), receiving a fully diversified diet and not exposed to antibiotic therapy for at least 3 months before the experiment, was collected. The sample was transferred to a tube containing 5 ml sterile, pre-reduced peptone water (0.1 %, pH 7), placed in an anaerobic jar, and immediately delivered to the laboratory before being homogenized. The faecal suspension was weighed and the volume adjusted with peptone water to obtain a final faecal concentration of 20 % (w/v). The faecal bacterial extract was immobilized in 1-2 mm diameter gel beads composed of 2.5 % gellan gum, 0.25 % xanthan gum and 0.2 % sodium citrate (w/v, SigmaAldrich), as described previously (Cleusix et al., 2008; Le Blay et al., 2009) . The entire process was performed under anaerobic conditions within 3 h after defecation. An inoculum of 60 ml (30 %, v/v) of fresh faecal beads was immediately transferred to the first reactors of both three-stage fermentation systems.
Ten-fold-concentrated overnight cultures of S. Typhimurium N-15, E. coli L1000 wt, E. coli L1000 MccB172 and B. thermophilum RBL67 were separately immobilized in the same way but aerobically. Bead colonization was performed with batch cultures in TSB for Salmonella (18 h, 37 uC, no pH control), in LB for E. coli (18 h, 37 uC, no pH control) and in MRSC for B. thermophilum RBL67 (24 h, 40 uC, pH 6.0, stirring at 150 r.p.m.). Colonized beads were washed in sterile CaCl 2 (0.1 mol l
21
) and used to inoculate the first or third reactor of the appropriate fermentation system, as described below.
Nutritive culture medium. A complex culture medium simulating the intestinal chyme of a young child was used to feed the first reactor of each three-stage fermentation system. The medium was similar to that described by Macfarlane et al. (1998) and modified for children by reducing the bile salt concentration from 0.4 to 0.05 g l 21 in order to reproduce the ileal chyme of a young child (Le . A 0.5 ml volume of a filter-sterilized (Minisart, 0.2 mm pore-size, Sartorius) vitamin solution (Michel et al., 1998) was added to 1 l of the autoclaved (15 min, 121 uC) medium. For prebiotic treatments, the medium was supplemented with 15 g l 21 high-solubility inulin (Orafti HIS, Beneo Orafti) before autoclaving.
Fermentation procedures. Faecal bead colonization was performed during batch fermentations for 48 h in two reactors (Sixfors, Infors) containing 30 % fresh beads and operated at a working volume of 200 ml at pH 5.7 and 37 uC, as previously described (Le . The fermented medium was replaced every 12 h with fresh nutritive medium. Then, two additional reactors (R2 and R3), halffilled with sterile nutritive medium, were connected in series to the first reactor, R1. Continuous fermentation was started by connecting a stirred feedstock vessel containing sterile nutritive medium (4 uC) via peristaltic pumps (Reglo Analog, Ismatec) to R1. Fermented medium from R1 was then pumped to R2 (working volume 400 ml), from R2 to R3 (working volume 400 ml), and finally from R3 to an effluent receiving vessel. The retention times and pH in R1, R2 and R3 were selected to mimic in vivo conditions in the child proximal, transverse and distal colons (Fallingborg et al., 1990; Wagener et al., 2004) . The total mean retention time of the system with a total volume of 800 ml was set at 25 h by adjusting the feed flow rate to 40 ml h 21 , resulting in mean retention times of 5 h for R1 and 10 h for R2 and R3. The headspaces of the reactors were continuously flushed with CO 2 to maintain anaerobic conditions. The pH in R1, R2 and R3 was automatically controlled at pH 5.7, 6.2 and 6.7, respectively, by adding 5 M NaOH.
The two three-stage reactor models (F1 and F2) were operated in parallel for a total of 65 days, which was divided into different periods, as shown in Fig. 1 . After bead colonization and stabilization for 10 days (Stab), S. Typhimurium N-15 beads (2.3610 9 c.f.u. g
) were added twice to the first reactor (R1) of both models (2 g on day 13 and 2.5 g on day 17) to induce Salmonella colonization. Continuous culture was carried out until day 22 (Sal). Beads containing the microcin B17-producing wild-type strain of E. coli (L1000 wt) were added on day 22 to R1 of F1 (5 g, 1.5610 9 c.f.u. g
, Ecol I) and repeated on day 36 in R3 (5 g, 1.4610 9 c.f.u. g
, Ecol II). For F2, the same protocol was applied but the wild-type E. coli strain was replaced by the mutant E. coli L1000 MccB172, which did not produce microcin B17. On day 44, 5 g B. thermophilum RBL67 beads (3.4610 10 c.f.u. g
) were added to R1 of both models (F1, Bif I; F2, Bif). This treatment was repeated on day 56 in the first fermentation model (F1, Bif II), while in the second fermentation model (F2), the nutritive medium was supplemented instead with 15 g inulin per day during the last fermentation period (Inulin). Effluents (13 ml) were simultaneously sampled daily in the morning from each reactor and processed within 1 h for the enumeration of S. Typhimurium N-15 by selective plating and of bacterial populations by real-time quantitative PCR (real-time qPCR) analysis, and for HPLC measurements.
Salmonella enumeration by plate counts. Serial 10-fold dilutions of effluent samples were carried out in peptone water (0.1 %, pH 7.0) and plated daily in duplicate on CHROMagar Salmonella medium (Becton Dickinson). Plates were incubated aerobically at 37 uC for 48 h. Genomic DNA was extracted from 1.5 ml effluent samples with the FastDNA SPIN Kit for Soil (MP Biomedicals) according to the manufacturer's instructions, with a final elution volume of 100 ml. Primer sets used for different bacterial groups in this study (Microsynth) are listed in Table 1 . Primers used for the enumeration of E. coli L1000 wt and E. coli L1000 MccB172 were designed using the Primer3 Input software (version 0.4.0; http://frodo.wi.mit.edu/ primer3) based on the mcbABCDEFG operon sequence (EMBL accession no. FM877811) and the sequence in the mutant strain after removal of the selection marker. Primers were checked for T m (melting temperature), secondary structure formation, G+C content and primer-dimer formation using the PCR Primer Stats software (http://www.bioinformatics.org/sms2/pcr_primer_stats.html).
PCR amplification and detection were performed with an ABI PRISM 7500-PCR sequence detection system (Applied Biosystems) in MicroAmp Fast Optical 96-Well Reaction Plates with Barcode (Applied Biosystems). Each reaction was run in duplicate and took place in a total volume of 25 ml, containing 12.5 ml 26 SYBR Green PCR Master Mix (Applied Biosystems), 0.2 mmol l 21 of the appropriate primers, and 1 ml template DNA diluted 10-or 100-fold depending on the targeted bacterial group. For the detection of B. thermophilum RBL67, reaction mixtures were composed of 12.5 ml qPCR MasterMix Plus LowRox (Eurogentec), 2.5 ml template DNA diluted 10-fold, 0.3 mmol l 21 of each primer and 0.1 mmol l
TaqMan probe. Real-time qPCR conditions were kept at the presettings of the ABI PRISM 7500-PCR sequence detection system, with an initial heating step of 2 min at 50 uC and a denaturation step of 10 min at 95 uC, followed by 40 amplification cycles of 95 uC for 15 s and 60 uC for 1 min. A final dissociation step was added for SYBR Green amplifications to improve amplification specificity. The fluorescent products were detected during the second step of each cycle. Melting curve analysis was performed after amplification using the 7500 Fast system SDS Software (version 1.4, Applied Biosystems) to evaluate the specificity of the primers and quality of the PCR. A standard curve for each primer pair was analysed in the same run and used for calculation of the number of 16S rDNA or gene copies detected in each sample. Mean copy number per millilitre effluent (MCN ml
) was calculated for the last 3 days of each period.
Metabolite analysis. Short-chain fatty acid (SCFA; acetate, propionate and butyrate) concentrations in effluent samples were determined by HPLC analysis, as described previously (Cleusix et al., 2008) .
Statistical analysis. All statistical analyses were performed using the statistical software JMP 8.0 for Windows (SAS Institute). Cell counts and MCN ml 21 values were log 10 -transformed to stabilize the variance and normalize the residual values for variance homogeneity.
The significance of slopes and intercepts of regression curves of logtransformed Salmonella cell concentrations in effluent samples versus time were tested for their difference from 0 using the t test (P,0.05). A multivariate analysis of variance (MANOVA) was performed to compare slopes of trend lines between reactors using the F test (P,0.05).
A one-way analysis of variance (ANOVA) was performed to test differences between mean metabolite concentrations measured by HPLC in effluent samples collected for the last 3 days of the experiment. An ANOVA was performed to test the effects of different treatments on mean log-transformed cell counts of Salmonella measured by selective plating and mean log-transformed MCN ml 21 of E. coli L1000 wt or MccB172 and B. thermophilum RBL67 (mean of the last 3 days of the periods), and on mean log-transformed MCN ml 21 of intestinal bacterial groups (mean of the last 3 days and three reactors) detected by real-time qPCR analyses. Means were compared using the Tukey-Kramer HSD test with a probability level of P,0.05.
RESULTS

Mutant construction
The microcin B17 activity of E. coli L1000 wt and its mutant MccB172 was tested with the double-agar layer assay (Fig. 2) . E. coli L1000 wt was highly active against the indicator organism E. coli NCTC 50154 and also inhibited S. Typhimurium N-15. In contrast, no inhibition was detected for the mutant strain E. coli L1000 MccB172 with both indicator strains.
Colonization of E. coli L1000 and B. thermophilum RBL67
The log 10 (MCN ml No signal was detected for E. coli L1000 wt and MccB172 in effluent samples before addition to F1 and F2, respectively. After adding 5 g E. coli L1000 wt (F1) and MccB172 (F2) beads to R1 (Ecol I and Ecol*I), MCN values were 1-1.5 log units higher for E. coli L1000 wt compared with MccB172, which was significant only in R2 and R3 (P,0.05). A second addition of E. coli L1000 beads to R3 in both systems led to a significant (P50.011) increase of E. coli L1000 counts in the effluent of R3 only for the mutant strain MccB172 (F2), with no effect for E. coli L1000 wt. Counts of E. coli L1000 wt decreased in both R1 and R2, and increased in R3 (P,0.05) by approximately 1 log unit after adding B. thermophilum RBL67 to R1 (Bif I). In contrast, no change of E. coli L1000 counts was observed for the mutant strain MccB172 (Bif in Fig. 2 . Double-agar layer activity assays for E. coli L1000 wt (a, b) and E. coli L1000 MccB17" (c, d) against target organisms E. coli NCTC 50154 (a, c) and S. Typhimurium N-15 (b, d) .
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F2) and after a second addition of B. thermophilum RBL67 to R1 (Bif II in F1). Inulin addition ('Inulin' in F2) induced a decrease of E. coli L1000 MccB172 counts in R1 and R2 (only significant for R1), with no change recorded in F3.
B. thermophilum RBL67 was not detected in effluent samples of F1 and F2 before addition to R1. After adding 5 g B. thermophilum RBL67 beads to R1, counts of B. thermophilum RBL67 reached similar high values in all reactors of F1 and F2, with respective mean values for log 10 (MCN ml 21 ) of 6.5±0.4 (Bif I) and 6.5±0.1 (Bif). After a second addition of B. thermophilum RBL67 beads to R1 of F1 (Bif II), counts only increased significantly (P50.035) in R3 compared with the previous period (Bif I), whereas no effect was detected for R1 and R2. Addition of inulin to the growth medium led to a sharp and significant (P,0.007) increase of B. thermophilum RBL67 ) (mean of last 3 days of the period). Period means with different letters are significantly different within F1 (roman type) and F2 (italic type), respectively, with the Tukey-Kramer HSD test (P ,0.05). Asterisks signify that means for the corresponding periods of F1 and F2 are significantly different with the F test. ) (mean of last 3 days of the period). Period means with different letters are significantly different within F1 (roman type) and F2 (italic type), respectively, with the TukeyKramer HSD test (P ,0.05).
Effects of two probiotic strains in a colonic model counts in all reactors of F2 of up to 3 log 10 (MCN ml 21 ) units.
Effects of probiotic and prebiotic treatments on Salmonella propagation
Daily Salmonella concentrations determined by selective plating during 65-day fermentations in F1 and F2 are presented in Fig. 5 , and mean concentrations detected during the last 3 days of each fermentation period are displayed in Table 2 .
After the first addition of 2 g S. Typhimurium N-15 beads, Salmonella was detected in the effluents of all reactors after 1 day but decreased steadily thereafter. A second addition of 2.5 g S. Typhimurium N-15 beads was performed and a continuous increase of Salmonella counts was recorded in all reactors of F1 and F2, reaching at the end of the Salmonella stabilization period (Sal) higher levels in R1 and R2 compared with R3, with means of 5.8±0.3, 5.6±0.5 and 4.3±0.5 log c.f.u. ml 21 , respectively.
Effects of E. coli L1000. The addition of 5 g E. coli L1000 wt or MccB172 beads to R1 further stimulated Salmonella growth during the following 14-day period in F1 and F2 (Fig. 5) . Salmonella counts increased linearly with time (P,0.0001) in all reactors, with a higher rate in R2 compared with R1 and R3 for both models. A second addition of 5 g E. coli L1000 beads in the distal reactor (R3) of F1 and F2 on day 36 had no significant effect on Salmonella counts in the reactor effluent (Ecol II and Ecol*II). After E. coli L1000 addition, Salmonella counts in ], measured daily by plate counts in effluents of the proximal (R1), transverse (R2) and distal (R3) colon reactors of fermentations F1 and F2. Regression lines were calculated over the time period from day 14 to 37 for F1 (solid lines) and F2 (dashed lines). * and 1, addition of 5 g E. coli L1000 wt and E. coli L1000 MccB17" beads to F1 and F2, respectively; 4addition of 5 g B. thermophilum RBL67 beads; 3addition of 5 g B. thermophilum RBL67 beads to F1 and start of nutritive medium supplementation with inulin (15 g per day) for F2.
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all reactors of F1 and F2 were equal or higher to 6.0 log 10 (c.f.u. ml 21 ) ( Table 2) .
Effects of B. thermophilum RBL67. Addition of 5 g B. thermophilum RBL67 beads on day 44 to R1 showed no significant effects on Salmonella counts in all three reactors of F1 and F2, which were in the range from 6.1±0.6 to 7.2±0.2 log 10 (c.f.u. ml 21 ) during the last 3 days of the Bif I (F1) and Bif (F2) periods (Table 2 ). Subsequent addition of 5 g B. thermophilum RBL67 beads to R1 on day 55 had no significant effect on Salmonella counts (Bif II, F1) compared with the previous Bif I period.
Effects of inulin. Supplementation of the nutritive medium with inulin during the final experimental period of F2 (Inulin) led to significantly (P50.037) increased levels of Salmonella in R3, with no detectable effects in R1 and R2.
Effects of Salmonella, probiotic and prebiotic treatments on main gut microbiota populations
MCN (ml effluent)
21 values of intestinal populations measured by real-time qPCR during the last 3 days of each experimental period were not significantly different for the proximal, transverse and distal reactors. Therefore, the mean MCN values calculated for the three reactors are presented in where a significant (P50.001) decrease from 9.4±0.4 to 7.9±0.4 log 10 (MCN ml 21 ) was measured. MCN ranges of bacterial groups measured during Stab in the effluents of the different reactors were similar to those of the faecal inoculum, except for Enterobacteriaceae, for which the MCN values were about 3 log units higher than for the faecal inoculum.
Salmonella addition to F1 and F2 had no significant (P.0.05) effects on Bifidobacterium spp. and Enterobacteriaceae populations, but was accompanied by a significant increase of Lactobacillus/Leuconostoc/Pediococcus spp. counts, from 3.4±0.3 (Stab) to 4.4±0.5 (Sal) log 10 (MCN ml Effects of E. coli L1000. No significant (P.0.05) changes of Bifidobacterium spp. and Enterobacteriaceae populations were measured during the first E. coli L1000 treatments [Ecol I (F1) and Ecol*I (F2)], and MCN values of E. coli L1000 were 3-5 log units lower compared with total Enterobacteriaceae. MCN values for Lactobacillus/Leuconostoc/Pediococcus spp. increased significantly (P,0.0001) with the first addition of E. coli L1000 wt (F1, +1 log unit) or MccB172 (F2, +0.8 log unit) to levels similar (P.0.05) to those measured in the faecal inoculum [5.1 log 10 (MCN ml 21 )]. No significant population changes were detected after the second addition of E. coli L1000, except for a small but significant (P50.032) increase of Enterobacteriaceae from 8.3±0.3 (Ecol*I) to 8.7±0.2 log 10 (MCN ml 21 ) (Ecol*II) in F2.
Effects of B. thermophilum RBL67. The first addition of B. thermophilum RBL67 to F1 (Bif I) and F2 (Bif) had no significant (P.0.05) effects on Bifidobacterium spp. and Enterobacteriaceae populations. Counts of B. thermophilum RBL67 during these periods were equal to total Bifidobacterium spp. counts. Lactobacillus/Leuconostoc/Pediococcus counts increased significantly (P50.032) only in F2 compared with the previous Ecol*II period, and stabilized at 5.8±0.3 log 10 (MCN ml 21 ) (Bif I, Bif) in both F1 and F2. In contrast, the second addition of B. thermophilum RBL67 in F1 (Bif II) was accompanied by a small (P50.029) decrease of Bifidobacterium spp. from 6.8±0.3 (Bif I) to 6.4±0.2 (Bif II) log 10 (MCN ml
21
) and a significant (P,0.0001) increase of Lactobacillus/Leuconostoc/Pediococcus spp. from 5.7±0.3 (Bif I) to 6.7±0.2 (Bif II) log 10 (MCN ml
).
Effects of inulin. Inulin addition in F2 resulted in a sharp and significant (P,0.0001) increase of both Lactobacillus/ Leuconostoc/Pediococcus spp. and Bifidobacterium spp. populations [.2 and 1.5 log 10 (MCN ml 21 ), respectively, in all reactors], concomitant with B. thermophilum RBL67 counts.
Effects of probiotic and prebiotic treatments on gut metabolic activity
No periodic effects (except for inulin addition) were detected on SCFA concentrations and ratios measured by HPLC. Therefore, mean SCFA concentrations and ratios calculated for the last 3 days of all experimental periods for different reactors are presented in Table 4 . Stable levels of total SCFA concentrations were measured in all reactors for both F1 and F2, with increasing values from the proximal (R1) to the distal (R3) colonic reactors. SCFA concentrations and ratios were similar for F1 and F2 (with the exception of the last inulin period; Table 4 ). Inulin addition in F2 led to a significant (P,0.05) increase in butyrate from 46.8±0.9, 54.3±1.5 and 52.4±0.5 mmol l 21 to 88.4±1.8, 105.1±6.0 and 101.1±3.8 mmol l 21 in R1, R2 and R3, respectively. Butyrate accounted for approximately 50 % of total SCFA compared with only 35 % during the previous Bif period. A concomitant reduction in proportion of acetate from 56 to 44 % was measured, whereas propionate remained unchanged.
DISCUSSION
The development of biological alternatives to antibiotics in order to treat infections and address the increasing A. Zihler and others prevalence of antibiotic-resistant and highly invasive pathogenic bacteria is of high public interest. Probiotic bacteria have great potential to complement or substitute conventional antibiotic treatments. Beneficial properties such as anti-Salmonella activity are, however, strainspecific and must be assessed separately for each probiotic bacterium. Two promising probiotic strains isolated from human faeces were tested in this study, E. coli L1000 and B. thermophilum RBL67 (von Ah et al., 2007; Zihler et al., 2009) . These have been shown to produce proteinaceous antimicrobial compounds with high and broad activity against Salmonella when assessed with simple antagonistic tests.
The human colon constitutes a protective and nutrientrich habitat for trillions of bacteria living in symbiosis with the host (Gaskins et al., 2008) . This dense and hostdependent microbial community has established an ecological mutualism with the host that confers a powerful barrier effect against pathogenic invaders, referred to as colonization resistance (Barth et al., 2009) . The ability to protect the host from invading pathogens presupposes that probiotics are able to transiently occupy a specific ecological niche in adequate numbers for optimal functionality. Barth et al. (2009) were able to show recently that the probiotic E. coli strain Nissle 1917 producing colicin has the capacity to adapt easily to the intestinal milieu of healthy conventional piglets, allowing persistence and replication in the gut. There are, however, no studies investigating the competitiveness of bacteriocinogenic strains compared with negative mutants for intestinal colonization and efficacy to counteract pathogens. In our study, E. coli L1000, independently of the presence of genetic determinants for microcin B17 production, was not able to colonize in vitro a complex gut microbiota at a high level [¡5.8 log 10 (MCN ml
21
) during the Ecol periods], even after high inoculation with 6610 9 cells immobilized in beads to induce colonization. This addition considerably exceeds the colonic delivery of probiotics at the recommended daily dose of 10 8 -10 9 cells believed to exert a beneficial effect on the host (Gill & Prasad, 2008) , while accounting for the potentially high viability loss during passage through the upper gastrointestinal tract. Accordingly, E. coli L1000 addition did not significantly affect gut microbiota composition or metabolic activity, except for an increase of the Lactobacillus/Leuconostoc/ Pediococcus population, although it strongly stimulated Salmonella growth. It has been previously shown that addition of Salmonella to a proximal reactor of an in vitro intestinal colonic fermentation model with immobilized child faecal microbiota stimulates the growth of the Clostridium coccoides-Eubacterium rectale group , which also belongs to the phylum Firmicutes. The inability of E. coli L1000 to stabilize at high levels in our model could also be explained by the high levels of Enterobacteriaceae with similar environmental requirements in the intestinal ecosystem of the donor. Microcin B17 production did not confer a significant ecological advantage upon E. coli L1000 wt over other Enterobacteriaceae, although microcin B17 has been shown to be active against Salmonella and other Enterobacteriaceae (Pons et al., 2002) . However, the E. coli L1000 wt population was significantly higher in R2 and R3 after the first inoculation of the strain in R1 (Ecol I) compared with the bacteriocin-negative mutant (Ecol*I), possibly due to in situ microcin B17 production. Stecher et al. (2010) have recently provided evidence that the presence of closely related strains can enhance the possibility of invasion of exogenous bacteria into the gut ecosystem. Mice harbouring high levels of gut lactobacilli are more efficiently colonized by a commensal and orally administered Lactobacillus reuteri RR strain. In addition, those authors provide evidence that individuals with high commensal Enterobacteriaceae densities are more susceptible to Salmonella-induced gut inflammation. Our data that show a stimulation of Salmonella growth after addition of E. coli L1000 to a gut microbiota already highly colonized with Enterobacteriaceae support this mechanism.
In contrast to E. coli L1000, B. thermophilum RBL67 colonized the intestinal microbiota at high levels after the first addition and accounted for a very high proportion (~70 %) of the total bifidobacteria population. In a previous study, we showed that B. thermophilum RBL67 added to a reactor simulating a child proximal colon made up to 12 % of total bifidobacteria (A. Zihler and others, unpublished results). Although the metabolic activity and composition of the intestinal ecosystem were little changed upon B. thermophilum RBL67 addition, a significant decrease in bifidobacteria counts was observed, possibly explained by thermophilicin B67 production affecting closely related bacteria. In addition, B. thermophilum RBL67 was highly active against S. Typhimurium M557, when added to the reactor preventively before or curatively after Salmonella colonization. Compared with the present study, Salmonella counts were about 1.5 log units lower before the addition of strain RBL67. Therefore, very different B. thermophilum RBL67 : Salmonella ratios (3050 : 1 and 2 : 1, respectively) were reached. The determination of the required probiotic dose for a targeted anti-pathogenic effect is difficult because the optimal concentration depends on several factors, including the probiotic organism, duration of application, delivery matrix (food or pharmaceutical) and the targeted population group (de Vrese & Schrezenmeir, 2008) . For example, a dose-efficacy study revealed that a 1-week Lactobacillus rhamnosus GG (LGG) treatment was equally effective at two dosages (10 10 and 10 12 c.f.u. twice per day) in decreasing the frequency and duration of rotavirus-induced acute watery diarrhoea in Indian children (Basu et al., 2009) , although data on the LGG : rotavirus ratios in the gut are lacking. To our knowledge, no study has investigated probiotic : pathogen ratios in the gut for maximal enteric protection, especially against Salmonella.
Inulin addition produced a large increase of lactobacilli counts and a pronounced bifidogenic effect accompanied by a shift in SCFA ratios towards elevated butyrate levels, as observed in previous studies (Kleessen et al., 2001;  Effects of two probiotic strains in a colonic model Langlands et al., 2004; Le Blay et al., 2009) . Interestingly, addition of inulin also led to a sharp increase of B. thermophilum RBL67 counts in all three reactors, and stimulated the growth of Salmonella in the distal colon reactor R3. Several studies have reported a correlation between the administration of different prebiotics (including inulin) and an enhanced severity of Salmonella infection in rats and mice (Bovee-Oudenhoven et al., 2003; Petersen et al., 2009; Ten Bruggencate et al., 2003 , 2004 with increased translocation of Salmonella, although these effects are not always correlated with an enhanced pathogen colonization of the gut.
In conclusion, data obtained with our in vitro intestinal fermentation model of Salmonella colonization in the child colon reflect a lack of efficacy of microcin B17-producing E. coli L1000 to inhibit Salmonella, in contrast to the high efficacy displayed by this strain in simple in vitro antagonistic tests . Although simple in vitro activity assays are practical and useful for first screening of probiotics active against Salmonella, more complete models reflecting the complex gut microbiota and environments are required to assess their efficacy and provide information on the mechanisms of probiotics for enteric protection within a complex microbial ecosystem. This validation step is important before considering in vivo testing with animal models. Indeed, several biotic factors are difficult to reproduce in vitro, and especially host immune and neuroendocrine responses are lacking in in vitro colonic fermentation models. Therefore, we are currently testing with intestinal epithelial cell models the in vitro effects on the host cell response of effluent samples produced by the colonic fermentation model and containing a child gut microbiota, Salmonella and probiotics. Such combined in vitro models could provide a more complete assessment of the potential and mechanisms of probiotics against pathogen infection in the gut.
